Alembic Pharmaceuticals Quarterly Results for Trading Insights
APLLTD • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹184 Cr
QSept 2025
Alembic Pharmaceuticals Quarterly Results Key Highlights
- Revenue of ₹1,919 Cr in Sept 2025 (+7.6% vs Mar 2025, +14.4% vs Sept 2024)
- Net Profit of ₹184 Cr in Sept 2025 (+17.2% vs Mar 2025, +20.3% vs Sept 2024)
- EBITDA of ₹324 Cr in Sept 2025 (+13.3% vs Mar 2025)
- Operating Margin of 17.0% in Sept 2025 (+2.0pp vs Mar 2025)
- Earnings Per Share of ₹9.40 in Sept 2025 (+17.8% vs Mar 2025)
Alembic Pharmaceuticals Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 1,919 | 1,784 | 1,717 | 1,892 | 1,678 | 7.6% | 14.4% |
| Net Profit (₹ Cr) | 184 | 157 | 154 | 132 | 153 | - | - |
| EBITDA (₹ Cr) | 324 | 286 | 287 | 265 | 270 | - | - |
| EPS (₹) | 9.40 | 7.98 | 7.85 | 6.76 | 7.79 | - | - |
| Operating Margin (%) | 17.0% | 15.0% | 16.0% | 13.0% | 15.0% | - | - |
Alembic Pharmaceuticals Share Price Trend Around Quarterly Results
Visualize Alembic Pharmaceuticals's 1-year price movement across quarterly results — ideal for logging trades in Alembic Pharmaceuticals share price
chart using Tickjournal. All values in ₹.
Related Pages for Alembic Pharmaceuticals
Additional stock information and data for APLLTD
Revenue Trend (₹ Cr)
Dec 2025
1,892
Jun 2025
1,717
Mar 2025
1,784
Sept 2025
1,919
Net Profit Trend (₹ Cr)
Dec 2025
132
Jun 2025
154
Mar 2025
157
Sept 2025
184
Operating Margin Trend (%)
Dec 2025
13.0%
Jun 2025
16.0%
Mar 2025
15.0%
Sept 2025
17.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Alembic Pharmaceuticals quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹416,764.48 Cr | 1784.5 | 14,875 | 3,125 | +10.8% | - | 21.0% | 137.3 |
|
Divis Laboratories
Sept 2025 |
₹170,125.54 Cr | 6364.5 | 2,860 | 689 | +7.1% | - | 24.1% | 245.1 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹146,658.56 Cr | 4353.4 | 3,219 | 591 | +11.3% | - | 18.4% | 248.2 |
|
Cipla
Sept 2025 |
₹109,178.44 Cr | 1326.4 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.3 |
|
Dr Reddys Laborator…
Sept 2025 |
₹107,358.50 Cr | 1313.5 | 9,135 | 1,337 | +1.1% | - | 14.6% | 81.2 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores